"The COVID-19 pandemic writes its own rules".
Last month, UQ vaccine project co-leader Professor Paul Young said the early indications suggested there were minimal side effects to the jab.
"We. made a prudent decision to back a number of vaccines". It surpassed the previous Dec 3 record of 2,861 deaths and was the first time the virus has claimed 3,000 United States lives or more in a single day. "This is why we made sure there were four contracts we signed to make sure that we got a vaccine and this is intrinsically very hard science that UQ and around the world is trying to break".
The Republican-led Senate was expected to vote on the measure as early as yesterday and send it to President Donald Trump in time to avoid a government shutdown.
Offering a new glimmer of hope, however, some officials said vaccinations could begin as soon as this weekend, and states have escalated plans for distribution.
A panel of independent medical experts was due to decide later on Thursday whether to recommend that the U.S. Food and Drug Administration authorize emergency use of a vaccine from Pfizer Inc and German partner BioNTech SE.
In a sign that approval could be swift, documents released by the FDA ahead of the review raised no new red flags over the safety or efficacy of the vaccine.
The announcement comes as the Food and Drug Administration is set to decide whether to grant an emergency use authorization for a vaccine developed by U.S. pharmaceutical giant Pfizer and its partner.
Nine out of 10 people in dozens of poor nations could miss out on getting vaccinated against Covid-19 next year because rich countries have hoarded far more doses than they need, campaigners said on Wednesday.
"By buying up the vast majority of the world's vaccine supply, rich countries are in breach of their human rights obligations", Steve Cockburn, Amnesty International's Head of Economic and Social Justice, said in a statement.
The city will allocate its initial doses to its 34 hospitals in the week of Dec 14, officials said.
The department is prioritizing DOD personnel to receive the vaccine based on CDC guidance, first focusing on those providing direct medical care, maintaining essential national security and installation functions, deploying forces, and those beneficiaries at the highest risk for developing severe illness from COVID-19 before other members of the DOD population.
Nursing home residents and staff have also felt the burden. A study by the Duke University of the USA shows a huge gap in the vaccine purchase of rich nations and developing countries.